Enlibio，Your biological research partner
！
Wuhan
Enlibio
Biotech
Co.,Ltd
2008-2024
Home
Home
Products
Nav
News
Nav
Contact Us
Nav
About Us
Nav
Distributors
Nav
Sitemap
Nav
Human ELISA Kits
Mouse ELISA kits
Rat ELISA kits
Other species ELISA kits
ELISA Kit Assist Reagents
ELISAs
Primary Antibody
Secondary Antibody
Industrial Antibody development
Antibody Development Services
Antibody Related Reagents
Western blot Reagents
Immunohistochemistry Reagents
Antibodies
Recombinant Proteins
Natural Proteins
Peptides
Protein service
Peptide service
Immunogens
Cell Line
Download Manual
Enlibio News
Article/Review
Contact Us
Technical Support
Messages
About Us
Job Opportunity
Company structure
Picture show
Article/Review
Nanoparticle-mediated TRPV1 channel blockade amplifies cancer thermo-immunotherapy via heat shock fa
[ Article/Review ]
2023-05-05
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs n
[ Article/Review ]
2023-05-05
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing i
[ Article/Review ]
2023-05-05
Nucleocytoplasmic transport of active HER2 causes fractional escape from the DCIS-like state
[ Article/Review ]
2023-04-27
Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
[ Article/Review ]
2023-04-27
Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients
[ Article/Review ]
2023-04-24
Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors
[ Article/Review ]
2023-04-24
Oncogenic drivers dictate immune control of acute myeloid leukemia
[ Article/Review ]
2023-04-24
Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during earl
[ Article/Review ]
2023-04-06
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in
[ Article/Review ]
2023-04-06
Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therape
[ Article/Review ]
2023-04-06
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to
[ Article/Review ]
2023-03-24
Epigenetic state determines the in vivo efficacy of STING agonist therapy
[ Article/Review ]
2023-03-24
Evolution of synchronous female bilateral breast cancers and response to treatment
[ Article/Review ]
2023-03-15
Non-canonical functions of SNAIL drive context-specific cancer progression
[ Article/Review ]
2023-03-15
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory
[ Article/Review ]
2023-03-15
Single-cell transcriptome profiling of the stepwise progression of head and neck cancer
[ Article/Review ]
2023-03-06
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerabi
[ Article/Review ]
2023-03-06
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non
[ Article/Review ]
2023-03-03
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A
[ Article/Review ]
2023-03-03
Prev
1
2
3
4
...
64
Next
mail:
info@enlibio.com
mail:
sale@enlibio.com
Tel:+86-027-87610298
mail:
alex@enlibio.com
mail:
order@enlibio.com
Tel:
+86-027-87610297
Add
:
B105,Building C1,R&D Building,Zone B,C,D,Wuhan National Bio-Industry Base,No.666 Gaoxin Avenue,East Lake New Technology Development Zone, Wuhan, China
